Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) EPS (Basic): 2023-2025

Historic EPS (Basic) for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to -$0.19.

  • Day One Biopharmaceuticals' EPS (Basic) fell 150.00% to -$0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 47.57%. This contributed to the annual value of -$1.02 for FY2024, which is 56.96% up from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' EPS (Basic) stood at -$0.19, which was up 34.48% from -$0.29 recorded in Q2 2025.
  • Over the past 5 years, Day One Biopharmaceuticals' EPS (Basic) peaked at $0.38 during Q3 2024, and registered a low of -$0.72 during Q1 2024.
  • Its 3-year average for EPS (Basic) is -$0.37, with a median of -$0.45 in 2023.
  • Per our database at Business Quant, Day One Biopharmaceuticals' EPS (Basic) soared by 170.37% in 2024 and then slumped by 480.00% in 2025.
  • Day One Biopharmaceuticals' EPS (Basic) (Quarterly) stood at -$0.64 in 2023, then declined by 7.81% to -$0.69 in 2024, then crashed by 150.00% to -$0.19 in 2025.
  • Its EPS (Basic) stands at -$0.19 for Q3 2025, versus -$0.29 for Q2 2025 and -$0.35 for Q1 2025.